A naturally occurring deletion in the SRY promoter region affecting the Sp1 binding site is associated with sex reversal

Journal of Endocrinological Investigation

Volumn 28, Issue 9, 2005, Pages 651-656

  Assumpcao J G ^a   Ferraz, L F Caldas ^a   Benedetti, C E ^b   Maciel Guerra, A T ^a   Guerra Jr , G ^a   Marques De Faria, A P ^a   Baptista, M T Matias ^a   De Mello, M P ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b LABORATÓRIO NACIONAL DE LUZ SÍNCROTRON   (Brazil)

Author keywords

46,XY gonadal dysgenesis; 46,XY sex reversal; Sex determination; SRY; SRY mutations

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CRYPTORCHISM; GEL MOBILITY SHIFT ASSAY; GENE DELETION; GENE MUTATION; GENE SEQUENCE; GONADAL DYSGENESIS; HUMAN; HYPOSPADIAS; IN VITRO STUDY; SEX DIFFERENCE; SEX TRANSFORMATION; SRY GENE; TESTIS DEVELOPMENT;

EID: 31544473451     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03347266     Document Type: Article

References (35)

1. Anderson GM, Freytag SO. Synergistic activation of a human promoter in vivo by transcription factor Sp1. Mol Cell Biol 1911, 11: 1935-43.
2. Koopman P, Gubbay J, Vivian N, Goodfellow P, Lovell-Badge R. Male development of chromosomally female mice transgenic for Sry. Nature 1991, 351: 117-21.
3. Behlke MA, Bogan JS, Beer-Romero P, Page DC. Evidence that the SRY protein is encoded by a single exon on the human Y chromosome. Genomics 1993, 17: 736-9.
4. Sinclair A H, Berta P, Palmer M S, et al. A gene from the human sex-determining region encodes a protein with homology to a conserved DMA-binding motif. Nature 1990, 346: 240-4.
5. Giese K, Pagel J, Grosschedl R. Distinct DNA-binding properties of the high mobility group domain of murine and human SRY sex-determining factors. Proc Natl Acad Sci USA 1994, 91: 3368-72.
6. Harley VR, Lovell-Badge R, Goodfellow PN. Definition of a consensus DNA binding site for SRY. Nucleic Acids Res 1994, 22: 1500-1.
7. Pontiggia A, Whitfield S, Goodfellow PN, Lovell-Badge R, Bianchi ME. Evolutionary conservation in the DNA-binding and -bending properties of HMG-boxes from SRY proteins of primates. Gene 1995, 154: 277-80.
8. Cameron FJ, Sinclair AH. Mutations in SRYand SOX9, testis-determining genes. Hum Mutat 1997, 9: 388-95.
9. Hawkins JR. Genetics of XY sex reversal. J Endocrinol 1995, 147: 183-7.
10. Assumpção JG, Benedetti CE, Maciel-Guerra AT, Guerra Jr G, Scolfaro R, de Mello MP. Novel mutations affecting SRY DNA-binding activity: the HMG box N65H associated with 46,XY pure gonadal dysgenesis and the familial non-HMG box R30I associated with variable phenotypes. J Mol Med 2002, 80: 782-90.
11. Hawkins JR, Taylor A, Goodfellow PN, Migeon CJ, Smith D, Berkovitz GD. Evidence for increased prevalence of SRY mutations in XY females with complete rather than partial gonadal dysgenesis. Am J Hum Genet 1992, 51: 979-84.
12. Uehara S, Hashiyada M, Sato K, Nata M, Funato T, Okamura K. Complete XY gonadal dysgenesis and aspects of the SRY genotype and gonadal tumor formation. J Hum Genet 2002, 47: 279-84.
13. McElreavey K, Vilain E, Abbas N, et al. XY sex reversal associated with a deletion 5′ to the SRY "HMG box" in the testis-determining region. Proc Natl Acad Sci USA 1992, 89: 11016-20.
14. Kwok C, Tyler-Smith C, Mendonca B, et al. Mutation analysis of the 2 kb 57prime; to SRY in XY females and XY intersex subjects. J Med Genet 1996, 33: 465-8.
15. Poulat F, Desclozeaux M, Tuffery S, Jay P, Boizet B, Berta P. Mutation in the 5′ noncoding region of the SRY gene in an XY sex-reversed patient. Hum Mutat 1998, (Suppl 1): S192-4.
16. Veitia RA, Fellous M, McElreavey K. Conservation of Y chromosome-specific sequences immediately 5′ to the testis determining gene in primates. Gene 1997, 199: 63-70.
17. Margarit E, Guillén A, Rebordosa C, et al. Identification of conserved potentially regulatory sequences of the SRY gene from 10 different species of mammals. Biochem Biophys Res Commun 1998, 245: 370-7.
18. Desclozeaux M, Poulat F, De Santa-Barbara P, et al. Characterization of two Sp1 binding sites of the human sex determining SRY promoter. Biochim Biophys Acta 1998, 1397: 247-52.
19. Shimamura R, Fraizer GC, Trapman J, Lau Y-FC, Saunders GF. The Wilms' tumor gene WT1 can regulate genes involved in sex determination and differentiation, SRY, Mullerian-inhibiting substance, and the androgen receptor. Clin Cancer Res 1997, 3: 2571-80.
20. Hossain A, Saunders GF. The human sex-determining gene SRY is a direct target of WT1. J Biol Chem 2001, 276: 16817-23. Epub 2001.
21. De Santa Barbara P, Méjean C, Moniot B, Malclès MH, Berta P, Boizet-Bonhoure B. Steroidogenic factor-1 contributes to the cyclic-adenosine monophosphate downregulation of human SRY gene expression. Biol Reprod 2001, 64: 775-83.
22. Clepet C, Schafer AJ, Sinclair AH, Palmer MS, Lovell-Badge R, Goodfellow PN. The human SRY transcript. Hum Mol Genet 1993, 2: 2007-12.
23. Su H, Lau Y-FC. Identification of the transcriptional unit, structural organization, and promoter sequence of the human sex-determining region Y (SRY) gene, using a reverse genetic approach. Am J Hum Genet 1993, 52 24-38.
24. Vilain E, Fellous M, McElreavey K. Characterization and sequence of the 5′flanking region of the human testis-determining factor SRY. Methods Mol Cell Biol 1992, 3: 128-34.
25. Berkovitz GD, Rechner MD, Zacur HW, et al. Clinical and pathologic spectrum of 46,XY gonadal dysgenesis, its relevance to the understanding of sex differentiation. Medicine (Baltimore) 1991, 10: 375-83.
26. Marcantonio SM, Fechner PY, Migeon CJ, Perlman EJ, Berkovitz GD. Embryonic testicular regression sequence, a part of the clinical spectrum of 46,XY gonadal dysgenesis. Am J Med Genet 1994, 49: 1-5.
27. Scolfaro MR, Cardinalli IA, Stuchi-Perez EG, et al. Morphometry and histology of gonads from 13 children with dysgenetic male pseudohermaphroditism. Arch Pathol Lab Med 2001, 125: 652-6.
28. Guerra-Jr G, de Mello MP, Assumpção JG, et al. True hermaphrodites in the southeastern region of Brazil, a different cytogenetic and gonadal profile. J Pediatr Endocrinol Metab 1998, 11: 519-24.
29. Sambrook J, Fristsch EF, Maniatis TE. Molecular cloning, a laboratory manual. New York: Cold Spring Harbor. 1989.
30. Schmitt-Ney M, Thiele H, Kalwaber P, Bardoni B, Cisternino M, Scherer G. Two novel SRY missense mutations reducing DNA binding identified in XY females and their mosaic fathers. Am J Hum Genet 1995, 56: 862-9.
31. Hawkins JR, Taylor A, Berta P, Levilliers J, Van der Auwera B, Goodfellow PN. Mutational analysis of SRY, nonsense and missense mutations in XY sex reversal. Hum Genet 1992, 88: 471-4.
32. Dynan WS, Tjian R. Control of eukaryotic messenger RNA synthesis by sequence-specific DNA-binding proteins. Nature 1985, 316: 774-8.
33. Kadonaga JT, Jones KA, Tjian R. Promoter-specific activation of RNA polymerase II transcription by Sp1. Trends Biochem Sci 1986, 11: 20-3.
34. Perkins ND, Edwards NL, Duckett CS, Agranoff AB, Schmid RM, Nabel G J. A cooperative interaction between NF-kappa B and Sp1 is required for HIV-1 enhancer activation. EMBO J 1993, 12: 3551-8.
35. Ukiyama E, Jancso-Radek A, Li B, et al. SRY and architectural gene regulation, the kinetic stability of a bent protein-DNA complex can regulate itstranscriptional potency. Mol Endocrinol 2001, 15: 363-77.